Estimated antiretroviral therapy coverage among children in El Salvador
El Salvador: Estimated antiretroviral therapy coverage among children was 26 in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among children in El Salvador, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among children in El Salvador is 26, measured in 2025.
Compared with earlier readings it is down 7.1% on the previous year and down 48.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among children in El Salvador peaked at 59 in 2014 and was at its lowest, 0, in 2000.
That places El Salvador 76th out of 89 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among children in El Salvador, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 5 | — |
| 2003 | 12 | +140.0% |
| 2004 | 21 | +75.0% |
| 2005 | 29 | +38.1% |
| 2006 | 36 | +24.1% |
| 2007 | 40 | +11.1% |
| 2008 | 43 | +7.5% |
| 2009 | 46 | +7.0% |
| 2010 | 50 | +8.7% |
| 2011 | 58 | +16.0% |
| 2012 | 52 | -10.3% |
| 2013 | 50 | -3.8% |
| 2014 | 59 | +18.0% |
| 2015 | 50 | -15.3% |
| 2016 | 43 | -14.0% |
| 2017 | 37 | -14.0% |
| 2018 | 32 | -13.5% |
| 2019 | 27 | -15.6% |
| 2020 | 28 | +3.7% |
| 2021 | 30 | +7.1% |
| 2022 | 28 | -6.7% |
| 2023 | 26 | -7.1% |
| 2024 | 28 | +7.7% |
| 2025 | 26 | -7.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 23.2 | 0 | 46 | 10 |
| 2010s | 45.8 | 27 | 59 | 10 |
| 2020s | 27.67 | 26 | 30 | 6 |
Countries ranked near El Salvador
- 74 Congo, Democratic Republic of the 28 compare
- 75 Liberia 27 compare
- 76 Costa Rica 26 compare
- 76 Tunisia 26 compare
- 79 Yemen 25 compare
- 79 Central African Republic 25 compare
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Population ages 75-79, female, annual growth rate 3.16 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0098 units per person (2025)
- Population ages 75-79, male, annual growth rate 2.23 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0063 units per person (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among children in El Salvador?
- Estimated antiretroviral therapy coverage among children in El Salvador was 26 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among children recorded in El Salvador?
- The highest recorded value was 59 in 2014.
- What is the lowest estimated antiretroviral therapy coverage among children recorded in El Salvador?
- The lowest recorded value was 0 in 2000.
- How does El Salvador rank for estimated antiretroviral therapy coverage among children?
- El Salvador ranks 76th out of 89 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among children rising or falling in El Salvador?
- Over the last ten years it is down 48.0%. The long-run trend across the full record is rising.
- Where does this El Salvador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among children. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).